The Oncosearch | Oncotarget

Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells Research Paper

Ji Tae Kim, Jing Li, Jun Song, Eun Y. Lee, Heidi L. Weiss, Courtney M. Townsend, Jr., B. Mark Evers

Published Jul 27, 2015 · Vol. 6, No. 29 · pp. 26960-26970

Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells Research Paper

Andreas Koch, Sven Arke Lang, Peter Johannes Wild, Susanne Gantner, Abdo Mahli, Gerrit Spanier, Mark Berneburg, Martina MÃ¼ller, Anja Katrin Bosserhoff, Claus Hellerbrand

Published Jul 22, 2015 · Vol. 6, No. 32 · pp. 32748-32760

Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy Research Paper

Daniel Oâ€™Neill, Dominic Jones, Mark Wade, James Grey, Sirintra Nakjang, Wenrui Guo, David Cork, Barry R. Davies, Steve R. Wedge, Craig N. Robson, Luke Gaughan

Published Jul 20, 2015 · Vol. 6, No. 28 · pp. 26029-26040

Keywords: Prostate cancer, Androgen receptor, Mutation, Anti-androgen-resistance, SGK1

IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma Research Paper

Amy L. Myers, Lin Lin, Derek J. Nancarrow, Zhuwen Wang, Daysha Ferrer-Torres, Dafydd G. Thomas, Mark B. Orringer, Jules Lin, Rishindra M. Reddy, David G. Beer, Andrew C. Chang

Published Jul 17, 2015 · Vol. 6, No. 28 · pp. 25897-25916

Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model Research Paper

Devaraja Rajasekaran, Ayesha Siddiq, Jennifer L.S. Willoughby, Jessica M. Biagi, Lisa M. Christadore, Sarah A. Yunes, Rachel Gredler, Nidhi Jariwala, Chadia L. Robertson, Maaged A. Akiel, Xue-Ning Shen, Mark A. Subler, Jolene J. Windle, Scott E. Schaus, Paul B. Fisher, Ulla Hansen, Devanand Sarkar

Published Jul 17, 2015 · Vol. 6, No. 28 · pp. 26266-26277

IFN type III: in vivo NK cell response Editorial

Fernando Souza-Fonseca-Guimaraes, Arabella Young, Mark J. Smyth

Published Jul 4, 2015 · Vol. 6, No. 24 · pp. 19960-19961

Effector Tregs: middle-men in TGFÎ² activation Editorial

John J. Worthington, Mark A. Travis

Published Jun 29, 2015 · Vol. 6, No. 24 · pp. 19958-19959

Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis Research Paper

Carrie A Duckworth, Scott E Guimond, Paulina Sindrewicz, Ashley J Hughes, Neil S French, Lu-Yun Lian, Edwin A Yates, D Mark Pritchard, Jonathan M Rhodes, Jeremy E Turnbull, Lu-Gang Yu

Published Jun 23, 2015 · Vol. 6, No. 27 · pp. 23671-23687

Keywords: Galectin-3, metastasis, heparin

Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer Research Paper

Lacey M. Litchfield, Abir Mukherjee, Mark A. Eckert, Alyssa Johnson, Kathryn A. Mills, Shawn Pan, Viji Shridhar, Ernst Lengyel, Iris L. Romero

Published Jun 19, 2015 · Vol. 6, No. 27 · pp. 23548-23560

siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine Research Paper

Christine Di Cresce, Rene Figueredo, Mateusz Rytelewski, Saman Maleki Vareki, Colin Way, Peter J. Ferguson, Mark D. Vincent, James Koropatnick

Published Jun 15, 2015 · Vol. 6, No. 26 · pp. 22397-22409

ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma Research Paper

Katherine E. Hutchinson, Douglas B. Johnson, Adam S. Johnson, Violeta Sanchez, Maria Kuba, Pengcheng Lu, Xi Chen, Mark C. Kelley, Qingguo Wang, Zhongming Zhao, Mark Kris, Michael F. Berger, Jeffrey A. Sosman, William Pao

Published Jun 13, 2015 · Vol. 6, No. 26 · pp. 22348-22360

Digesting dietary miRNA therapeutics Editorial

Mark Yarmarkovich, Kendal D. Hirschi

Published Jun 8, 2015 · Vol. 6, No. 16 · pp. 13848-13849

Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma Research Paper

Jules Lin, Amy L. Myers, Zhuwen Wang, Derek J. Nancarrow, Daysha Ferrer-Torres, Amy Handlogten, Kimmy Leverenz, Julia Bao, Dafydd G. Thomas, Thomas D. Wang, Mark B. Orringer, Rishindra M. Reddy, Andrew C. Chang, David G. Beer, Lin Lin

Published Jun 1, 2015 · Vol. 6, No. 26 · pp. 22239-22257

Inhibition of muscle fibrosis results in increases in both utrophin levels and the number of revertant myofibers in Duchenne muscular dystrophy Research Paper

Oshrat Levi, Olga Genin, Corrado Angelini, Orna Halevy, Mark Pines

Published May 21, 2015 · Vol. 6, No. 27 · pp. 23249-23260

Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells Research Paper

Nitu Bansal, Prasun J. Mishra, Mark Stein, Robert S. DiPaola, Joseph R. Bertino

Published May 15, 2015 · Vol. 6, No. 17 · pp. 15321-15331

Dynamic treatment effect (DTE) curves reveal the mode of action for standard and experimental cancer therapies Research Paper

Kingshuk Roy Choudhury, Stephen T. Keir, Kathleen A. Ashcraft, Mary-Keara Boss, Mark W. Dewhirst

Published May 15, 2015 · Vol. 6, No. 16 · pp. 14656-14668

Clinical next generation sequencing to identify actionable aberrations in a phase I program Research Paper

Genevieve M. Boland, Sarina A. Piha-Paul, Vivek Subbiah, Mark Routbort, Shelley M. Herbrich, Keith Baggerly, Keyur P. Patel, Lauren Brusco, Chacha Horombe, Aung Naing, Siqing Fu, David S. Hong, Filip Janku, Amber Johnson, Russell Broaddus, Raja Luthra, Kenna Shaw, John Mendelsohn, Gordon B. Mills, Funda Meric-Bernstam

Published May 8, 2015 · Vol. 6, No. 24 · pp. 20099-20110

CD4⁺ and CD8⁺ T cells have opposing roles in breast cancer progression and outcome Research Paper

Yi Huang, Chunling Ma, Qunyuan Zhang, Jian Ye, Fang Wang, Yanping Zhang, Pamela Hunborg, Mark A. Varvares, Daniel F. Hoft, Eddy C. Hsueh, Guangyong Peng

Published Apr 29, 2015 · Vol. 6, No. 19 · pp. 17462-17478

Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases Research Paper

Naushad Ali, Parthasarathy Chandrakesan, Charles B. Nguyen, Sanam Husain, Allison F. Gillaspy, Mark Huycke, William L. Berry, Randal May, Dongfeng Qu, Nathaniel Weygant, Sripathi M. Sureban, Michael S. Bronze, Danny N. Dhanasekaran, Courtney W. Houchen

Published Apr 29, 2015 · Vol. 6, No. 24 · pp. 20327-20344

Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration Research Paper

Yekaterina Y. Zaytseva, Jennifer W. Harris, Mihail I. Mitov, Ji Tae Kim, D. Allan Butterfield, Eun Y. Lee, Heidi L. Weiss, Tianyan Gao, B. Mark Evers

Published Apr 20, 2015 · Vol. 6, No. 22 · pp. 18891-18904

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells Research Paper

Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells Research Paper

Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy Research Paper

IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma Research Paper

Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model Research Paper

IFN type III: in vivo NK cell response Editorial

Effector Tregs: middle-men in TGFÎ² activation Editorial

Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis Research Paper

Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer Research Paper

siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine Research Paper

ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma Research Paper

Digesting dietary miRNA therapeutics Editorial

Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma Research Paper

Inhibition of muscle fibrosis results in increases in both utrophin levels and the number of revertant myofibers in Duchenne muscular dystrophy Research Paper

Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells Research Paper

Dynamic treatment effect (DTE) curves reveal the mode of action for standard and experimental cancer therapies Research Paper

Clinical next generation sequencing to identify actionable aberrations in a phase I program Research Paper

CD4⁺ and CD8⁺ T cells have opposing roles in breast cancer progression and outcome Research Paper

Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases Research Paper

Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells Research Paper

Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells Research Paper

Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy Research Paper

IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma Research Paper

Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model Research Paper

IFN type III: in vivo NK cell response Editorial

Effector Tregs: middle-men in TGFÎ² activation Editorial

Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis Research Paper

Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer Research Paper

siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine Research Paper

ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma Research Paper

Digesting dietary miRNA therapeutics Editorial

Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma Research Paper

Inhibition of muscle fibrosis results in increases in both utrophin levels and the number of revertant myofibers in Duchenne muscular dystrophy Research Paper

Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells Research Paper

Dynamic treatment effect (DTE) curves reveal the mode of action for standard and experimental cancer therapies Research Paper

Clinical next generation sequencing to identify actionable aberrations in a phase I program Research Paper

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome Research Paper

Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases Research Paper

Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration Research Paper

CD4⁺ and CD8⁺ T cells have opposing roles in breast cancer progression and outcome Research Paper